EVO100
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EVO100, covering 2024-01-30 to 2024-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection [Phase 3]